ruxolitinib

Pronunciation: RUX oh LI ti nib

Brand: Jakafi

Jakafi

slide 1 of 4, Jakafi,

5 mg, round, white, imprinted with INCY, 5

Image of Jakafi
slide 1 of 4

Jakafi

slide 2 of 4, Jakafi,

10 mg, round, white, imprinted with INCY, 10

Image of Jakafi
slide 2 of 4

Jakafi

slide 3 of 4, Jakafi,

15 mg, oval, white, imprinted with INCY, 15

Image of Jakafi
slide 3 of 4

Jakafi

slide 4 of 4, Jakafi,

20 mg, oblong, white, imprinted with INCY, 20

Image of Jakafi
slide 4 of 4

What is the most important information I should know about ruxolitinib?

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

What is ruxolitinib?

Ruxolitinib is used in adults to treat myelofibrosis or polycythemia vera, which are bone marrow disorders that that affect your body's ability to produce blood cells.

Ruxolitinib is also used to treat graft versus host disease in adults and children at least 12 years old.

Ruxolitinib is usually given after other treatments have failed.

Ruxolitinib may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before taking ruxolitinib?

You should not use ruxolitinib if you are allergic to it.

Tell your doctor if you have ever had tuberculosis or if anyone in your household has tuberculosis. Also tell your doctor if you have recently traveled. Tuberculosis and some fungal infections are more common in certain parts of the world, and you may have been exposed during travel.

Tell your doctor if you have ever had:

  • any type of chronic infection;
  • kidney disease (or if you are on dialysis);
  • liver disease (especially hepatitis B);
  • skin cancer; or
  • high cholesterol or triglycerides (types of fat in the blood).

Using ruxolitinib may increase your risk of developing skin cancer. Talk to your doctor about this risk and what skin symptoms to watch for.

It is not known whether ruxolitinib will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

You should not breastfeed while you are using ruxolitinib, and for at least 2 weeks after your last dose.

Ruxolitinib is not approved to treat myelofibrosis or polycythemia vera in anyone younger than 18 years old.

How should I take ruxolitinib?

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Your doctor may occasionally change your dose. You will need frequent medical tests to help your doctor determine the best dose. When you first start taking ruxolitinib, your blood will need to be tested every 2 to 4 weeks.

You may take ruxolitinib with or without food. The ruxolitinib tablet can also be given through a nasogastric (NG) feeding tube.

Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you do not understand these instructions.

Store at room temperature away from moisture and heat.

You should not stop using ruxolitinib suddenly. Follow your doctor's instructions about tapering your dose.

You may be given other medications to help prevent infection. Keep using these medicines for as long as your doctor has prescribed.

What happens if I miss a dose?

Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking ruxolitinib?

Grapefruit may interact with ruxolitinib and lead to unwanted side effects. Avoid the use of grapefruit products.

What are the possible side effects of ruxolitinib?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may be similar to the symptoms of myelofibrosis. Call your doctor at once if you have:

  • blisters or painful skin rash;
  • changes in the size, shape, or color of a mole or skin lesion;
  • problems with speech, thought, vision, or muscle movement (these symptoms may start gradually and get worse quickly);
  • nausea, vomiting, weakness, general ill feeling;
  • pain or burning when you urinate;
  • low blood cell counts --fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath; or
  • signs of tuberculosis: fever, cough, night sweats, loss of appetite, weight loss, and feeling very tired.

Common side effects may include:

  • low blood cell counts;
  • fluid retention;
  • diarrhea;
  • dizziness; or
  • headache.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect ruxolitinib?

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Tell your doctor about all your other medicines, especially fluconazole.

This list is not complete and many other drugs may affect ruxolitinib. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Where can I get more information?

Your pharmacist can provide more information about ruxolitinib.

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.